Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Distribution of products was reduced in response to the recent civil unrest in Bangladesh, in the interest of employee safety, but it is now returning to normal levels. ‘The interim government of Bangladesh has indicated that it intends to address any ongoing unrest as a priority, and we expect to be able to resume normal distribution in the coming days,’ Beximco says. No significant damage was done to its manufacturing and distribution facilities, and the company says it doesn’t expect the disruption to have a ‘material impact’ on annual results.

More than 450 people were killed during the weeks of unrest leading up to the toppling earlier this month of ex-premier Sheikh Hasina, whose government was accused of human rights abuses, including the extrajudicial killing of thousands of her political opponents. Nobel laureate Muhammad Yunus returned from Europe after Hasina’s ouster to head a temporary administration tasked with democratic reforms in Bangladesh.

Current stock price: 36.50 pence, up 1.4% in London on Tuesday

12-month change: down 13%

Copyright 2024 Alliance News Ltd. All Rights Reserved.